EZH2抑制剂
| 英文名 | GSK126 | CAS号 | 1346574-57-9 |
| 试剂别名 |
GSK126;1-[(2S)-butan-2-yl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-3-methyl-6-(6-piperazin-1-ylpyridin-3-yl)indole-4-carboxamide;GSK-126;GSK-2816126;(S)-1-sec-butyl-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide;CS-1401;EZH2 inhibitor;GSK2816126A;GSK-2816126A;N-[(4,6-dimethyl-2-oxo-1,2-dihydro-3-pyridinyl)methyl]-3-methyl-1-[(1S)-1-methylpropyl]-6-[6-(1-piperazinyl)-3-pyridinyl]-1H-indole-4-carboxamide;QC-9703;N-[(4,6-Dimethyl-2-oxo-1,2-dihydro-3-pyridinyl)methyl]-3-methyl-1-((1S)-1-methylpropyl)-6-[6-(1-piperazinyl)-3-pyridinyl]-1H-indole-4-carboxamide
|
分子式 | C31H38N6O2 |
| 产品编号 | APEA3446 | 分子量 | 526.67 |
| MDL号 |
| 产品名称： | EZH2抑制剂 |
| 英文名称： | GSK126 |
| 英文别名： | GSK126;1-[(2S)-butan-2-yl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-3-methyl-6-(6-piperazin-1-ylpyridin-3-yl)indole-4-carboxamide;GSK-126;GSK-2816126;(S)-1-sec-butyl-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide;CS-1401;EZH2 inhibitor;GSK2816126A;GSK-2816126A;N-[(4,6-dimethyl-2-oxo-1,2-dihydro-3-pyridinyl)methyl]-3-methyl-1-[(1S)-1-methylpropyl]-6-[6-(1-piperazinyl)-3-pyridinyl]-1H-indole-4-carboxamide;QC-9703;N-[(4,6-Dimethyl-2-oxo-1,2-dihydro-3-pyridinyl)methyl]-3-methyl-1-((1S)-1-methylpropyl)-6-[6-(1-piperazinyl)-3-pyridinyl]-1H-indole-4-carboxamide |
| 中文别名： | GSK-126;GSK 126 |
| CAS No.： | 1346574-57-9 |
| 分子式： | C31H38N6O2 |
| 分子量： | 526.67 |
| 危险品级别： | |
| HS符号： | |
| 危害声明： |
